New drug mechanism: Researchers found a molecule that can engage two distinct E3 ligases to degrade cancer-related proteins, providing redundancy in treatment. Why it matters: Dual-ligase recruitment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results